Filing Flows › BeOne Medicines (ONC) › Operating margin
BeOne Medicines (ONC) operating margin by quarter
BeOne Medicines' operating margin was 22.2% in Q3 2026 (third quarter 2026), +3.1 pts from Q2 2026. Over the last 7 quarters it ranged from 1.0% (Q1 2025) to 22.2% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 22.2% | +3.1 pts | +10.6 pts |
| Q2 2026 | 19.1% | +2.6 pts | +12.4 pts |
| Q1 2026 | 16.5% | +4.2 pts | +15.5 pts |
| Q4 2025 | 12.4% | +0.8 pts | — |
| Q3 2025 | 11.5% | +4.9 pts | — |
| Q2 2025 | 6.7% | +5.7 pts | — |
| Q1 2025 | 1.0% | — | — |
Q3 2026 at a glance
BeOne Medicines, Q3 2026: revenue $1.9B (+34% year over year), operating margin 22.2%, net earnings $385M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.
Questions
What is BeOne Medicines' operating margin?
BeOne Medicines' operating margin was 22.2% in Q3 2026 (third quarter 2026), +3.1 pts from Q2 2026.
How has BeOne Medicines' operating margin changed?
Over the last 7 quarters it ranged from 1.0% (Q1 2025) to 22.2% (Q3 2026).